BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C - PubMed (original) (raw)

BMK1/ERK5 regulates serum-induced early gene expression through transcription factor MEF2C

Y Kato et al. EMBO J. 1997.

Abstract

Big MAP kinase 1 (BMK1), also known as ERK5, is a mitogen-activated protein (MAP) kinase member whose biological role is largely undefined. We have shown previously that the activity of BMK1 in rat smooth muscle cells is up-regulated by oxidants. Here, we describe a constitutively active form of the MAP kinase kinase, MEK5(D), which selectively activates BMK1 but not other MAP kinases in vivo. Through utilization of MEK5(D), we have determined that a member of the MEF2 transcription factor family, MEF2C, is a protein substrate of BMK1. BMK1 dramatically enhances the transactivation activity of MEF2C by phosphorylating a serine residue at amino acid position 387 in this transcription factor. Serum is also a potent stimulator of BMK1-induced MEF2C phosphorylation, since a dominant-negative form of BMK1 specifically inhibits serum-induced activation of MEF2C. One consequence of MEF2C activation is increased transcription of the c-jun gene. Taken together, these results strongly suggest that in some cell types the MEK5/BMK1 MAP kinase signaling pathway regulates serum-induced early gene expression through the transcription factor MEF2C.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Oncogene. 1991 Feb;6(2):229-35 - PubMed
    1. Mol Cell Biol. 1997 May;17(5):2615-23 - PubMed
    1. Mol Cell Biol. 1991 Sep;11(9):4466-72 - PubMed
    1. Nature. 1992 Jul 30;358(6385):414-7 - PubMed
    1. Genes Dev. 1992 Sep;6(9):1783-98 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources